Skip to content
★ Sign in to follow
Total declarations
138
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (61 ops.)
€11.7M

Latest filing published 20 Sept 2013 for Regeneron Pharmaceuticals, INC..

Insider track record

Disclosed buys
0
Disclosed sells
61
Signal history

No signal scores available.

William Roberts: trading record in brief

William Roberts discloses dealings in Regeneron Pharmaceuticals, Inc. to SEC (Form 4). In total, 138 filings cover trades dated from 17 November 2006 to 19 September 2013.

No open-market purchase appears, only 61 sales worth €11.7M. Outside the open market, there are 23 share grants and 34 option exercises. Since January 2013: no purchases and 1 sale on the market.

The newest entry dates from 20 September 2013: a transaction, in Regeneron Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to William Roberts

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations135 total

25 of 135 declarations